Abschluss eines nicht exklusiven Rabattvertrages nach§ 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Guanfacin (ATC-Code: N06BA21) innerhalb des Zeitraumes vom 01.11.2026 bis zum 31.10.2028 mit jederzeitiger Möglichkeit des Vertragsabschlusses während der Laufzeit („open-house-Modell“).

TENDER DESCRIPTION

For the active ingredient Guanfacine (ATC code: N06BA21), AOK Niedersachsen offers rebate agreements. For the period until the entry into force of exclusive agreements as a result of a formal procurement procedure in accordance with the provisions of Part 4 of the GWB, AOK Niedersachsen’s health insurance fund offers rebate agreements, without any selection decision, to all interested pharmaceutical companies. The contract award decisions are carried out within the framework of an “open-house model” and serve as a bridge between the start of generic competition (expiry of the patent) and the award of exclusive agreements. The rebate agreements offered are non-exclusive; agreements with all market participants (pharmaceutical companies) are desired by AOK Niedersachsen. In the open-house model, uniform conditions apply to all participants. Contract terms, conditions and access procedures are uniform—individual negotiations are generally not conducted. The contract terms are a maximum of twenty-four months; the earliest contract start date is 01.11.2026. All contracts end no later than 31.10.2028, regardless of the date on which the respective contract is concluded. Accession…

TENDER BRIEF

TENDER DOCUMENTS